Skip to content

Vagus Nerve Stimulation in Healthy Humans

Vagus Nerve Stimulation in Healthy Humans - Vagus Nerve Stimulation in Healthy Humans

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON31096
Enrollment
20
Registered
2007-07-12
Start date
2007-05-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammation inflammatory diseases

Interventions

Mechanical stimulation of the nervus Vagus in the right cymba conchae.

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Male subjects between 18 and 50 years of age. 2. No clinically significant findings during physical examination and hematological and biochemical screening. 3. Normal electrocardiogram. 4. Able to communicate well with the investigator and to comply with the requirements of the study. 5. No medication. 6. Written informed consent.

Exclusion criteria

Exclusion criteria: 1. Known diseases, including previously documented cardiac arrhythmias. 2. A history of smoking within the last six months, or regular consumption of greater than three Units of alcohol per day. 3. Administration of any investigational drug within 30 days of study initiation. 5. Donation of blood within 60 days, or loss greater than 400 ml of blood within 12 weeks of study initiation.

Design outcomes

Primary

MeasureTime frame
To obtain insight into the Vagus *tone* or the amount of Vagus nerve signals, heart rate variability will be determined. In addition, blood will be obtained before and at 0.5, 2, 5 and 24 hours after Vagus nerve stimulation for *ex vivo* tests evaluating a number of inflammatory responses.

Secondary

MeasureTime frame
Not applicable.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)